Methylphenidate restores novel object recognition in DARPP-32 knockout mice

Behavioural Brain Research

Volumn 253, Issue , 2013, Pages 266-273

  Heyser, Charles J ^a,b   McNaughton, Caitlyn H ^b   Vishnevetsky, Donna ^b   Fienberg, Allen A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FRANKLIN AND MARSHALL COLLEGE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

DARPP 32; Memory; Methylphenidate; Novel object recognition; Ritalin

Indexed keywords

DOPAMINE RECEPTOR; METHYLPHENIDATE; PHOSPHOPROTEIN DARPP 32; SODIUM CHLORIDE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPLORATORY BEHAVIOR; FEMALE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OBJECT RECOGNITION; PRIORITY JOURNAL; RECOGNITION; WILD TYPE;

DARPP-32; MEMORY; METHYLPHENIDATE; NOVEL OBJECT RECOGNITION; RITALIN;

ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DATA INTERPRETATION, STATISTICAL; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; EXPLORATORY BEHAVIOR; FEMALE; MALE; METHYLPHENIDATE; MICE; MICE, KNOCKOUT; PREGNANCY; RECOGNITION (PSYCHOLOGY); SEX CHARACTERISTICS;

EID: 84882769069     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.07.031     Document Type: Article

References (60)

1. Guide for the care and use of laboratory animals 1996, National Academy Press, Washington, DC.
2. Ainge J.A., Heron-Maxwell C., Theofilas P., Wright P., de Hoz L., Wood E.R. The role of the hippocampus in object recognition in rats: examination of the influence of task parameters and lesion size. Behavioural Brain Research 2006, 167:183-195.
3. Arnsten A.F. Modulation of prefrontal cortical-striatal circuits: relevance to therapeutic treatments for Tourette syndrome and attention-deficit hyperactivity disorder. Advances in Neurology 2001, 85:333-341.
4. Arnsten A.F., Li B.M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biological Psychiatry 2005, 57:1377-1384.
5. Bateup H.S., Santini E., Shen W., Birnbaum S., Valjent E., Surmeier D.J., et al. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:14845-14850.
6. Berlyne D.E. Novelty and curiosity as determinants of exploratory behavior. British Journal of Psychology 1950, 41:68-80.
7. Berlyne D.E. Curiosity and exploration. Science 1966, 153:25-33.
8. Besheer J., Jensen H.C., Bevins R.A. Dopamine antagonism in a novel-object recognition and a novel-object place conditioning preparation with rats. Behavioural Brain Research 1999, 103:35-44.
9. Bevins R.A., Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nature Protocols 2006, 1:1306-1311.
10. Bollen M., Peti W., Ragusa M.J., Beullens M. The extended PP1 toolkit: designed to create specificity. Trends in Biochemical Sciences 2010, 35:450-458.
11. Carlini V.P., Poretti M.B., Rask-Andersen M., Chavan R.A., Ponzio M.F., Sawant R.S., et al. Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 38:159-167.
12. Chopin P., Colpaert F.C., Marien M. Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents. Journal of Pharmacology and Experimental Therapeutics 2002, 301:187-196.
13. Chuhan Y.S., Taukulis H.K. Impairment of single-trial memory formation by oral methylphenidate in the rat. Neurobiology of Learning and Memory 2006, 85:125-131.
14. Dyne L.J., Hughes R.N. Effect of methylphenidate on activity and reactions to novelty in rats. Psychonomic Science 1969, 19:267-268.
15. Ehrman L.A., Williams M.T., Schaefer T.L., Gudelsky G.A., Reed T.M., Fienberg A.A., et al. Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice. Genes, Brain, and Behavior 2006, 5:540-551.
16. Ennaceur A. One-trial object recognition in rats and mice: methodological and theoretical issues. Behavioural Brain Research 2010, 215:244-254.
17. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behavioural Brain Research 1988, 31:47-59.
18. Fienberg A.A., Greengard P. The DARPP-32 knockout mouse. Brain Research: Brain Research Reviews 2000, 31:313-319.
19. Fienberg A.A., Hiroi N., Mermelstein P.G., Song W., Snyder G.L., Nishi A., et al. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 1998, 281:838-842.
20. Frank M.J., Moustafa A.A., Haughey H.M., Curran T., Hutchison K.E. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:16311-16316.
21. Fukui R., Svenningsson P., Matsuishi T., Higashi H., Nairn A.C., Greengard P., et al. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. Journal of Neurochemistry 2003, 87:1391-1401.
22. Gatley S.J., Pan D., Chen R., Chaturvedi G., Ding Y.S. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sciences 1996, 58:231-239.
23. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. Brain Research 1997, 777:1-12.
24. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., et al. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. Journal of Pharmacology and Experimental Therapeutics 2000, 295:51-57.
25. Halpain S., Girault J.A., Greengard P. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 1990, 343:369-372.
26. Hara M., Fukui R., Hieda E., Kuroiwa M., Bateup H.S., Kano T., et al. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons. Journal of Neurochemistry 2010, 113:1046-1059.
27. Hemmings H.C., Nairn A.C., Greengard P. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1. Journal of Biological Chemistry 1984, 259:14491-14497.
28. Heyser C.J., Chemero A. Novel object exploration in mice: not all objects are created equal. Behavioural Processes 2012, 89:232-238.
29. Heyser C.J., Fienberg A.A., Greengard P., Gold L.H. DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. Brain Research 2000, 867:122-130.
30. Heyser C.J., Pelletier M., Ferris J.S. The effects of methylphenidate on novel object exploration in weanling and periadolescent rats. Annals of the New York Academy of Sciences 2004, 1021:465-469.
31. Hotte M., Thuault S., Lachaise F., Dineley K.T., Hemmings H.C., Nairn A.C., et al. D1 receptor modulation of memory retrieval performance is associated with changes in pCREB and pDARPP-32 in rat prefrontal cortex. Behavioural Brain Research 2006, 171:127-133.
32. Hughes R.N. Behaviour of male and female rats with free choice of two environments differing in novelty. Animal Behaviour 1968, 16:92-96.
33. Kirk R.E. Experimental design: procedures for the behavioral sciences 1995, Thomson Brooks/Cole Publishing Co, Belmont, CA, US. 3rd ed.
34. Klein R.G. Pharmacotherapy of childhood hyperactivity: an update. Psychopharmacology: the Third Generation of Progress 1987, 1215-1224. Raven Press, New York. H.Y. Meltzer (Ed.).
35. McLean S.L., Idris N.F., Woolley M.L., Neill J.C. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: implications for mechanisms of improved cognitive function in schizophrenia. European Neuropsychopharmacology 2009, 19:440-450.
36. Nagai T., Takuma K., Kamei H., Ito Y., Nakamichi N., Ibi D., et al. Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex. Learning and Memory 2007, 14:117-125.
37. Nelson A.J., Thur K.E., Marsden C.A., Cassaday H.J. Dissociable roles of dopamine within the core and medial shell of the nucleus accumbens in memory for objects and place. Behavioral Neuroscience 2010, 124:789-799.
38. Ouimet C.C., Greengard P. Distribution of DARPP-32 in the basal ganglia: an electron microscopic study. Journal of Neurocytology 1990, 19:39-52.
39. Ouimet C.C., Miller P.E., Hemmings H.C., Walaas S.I., Greengard P. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. Journal of Neuroscience 1984, 4:111-124.
40. Pan D., Gatley S.J., Dewey S.L., Chen R., Alexoff D.A., Ding Y.S., et al. Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. European Journal of Pharmacology 1994, 264:177-182.
41. Robbins T.W., Koob G.F. Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system. Nature 1980, 285:409-412.
42. Roozendaal B., Okuda S., Van der Zee E.A., McGaugh J.L. Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6741-6746.
43. Rosa D.V., Souza R.P., Souza B.R., Guimaraes M.M., Carneiro D.S., Valvassori S.S., et al. DARPP-32 expression in rat brain after an inhibitory avoidance task. Neurochemical Research 2008, 33:2257-2262.
44. Salamone J.D. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behavioural Brain Research 1994, 61:117-133.
45. Salamone J.D., Correa M., Mingote S., Weber S.M. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. Journal of Pharmacology and Experimental Therapeutics 2003, 305:1-8.
46. Save E., Poucet B., Foreman N., Buhot M.C. Object exploration and reactions to spatial and nonspatial changes in hooded rats following damage to parietal cortex or hippocampal formation. Behavioral Neuroscience 1992, 106:447-456.
47. Scullion G.A., Kendall D.A., Sunter D., Marsden C.A., Pardon M.C. Central noradrenergic depletion by DSP-4 prevents stress-induced memory impairments in the object recognition task. Neuroscience 2009, 164:415-423.
48. Segovia K.N., Correa M., Lennington J.B., Conover J.C., Salamone J.D. Changes in nucleus accumbens and neostriatal c-Fos and DARPP-32 immunoreactivity during different stages of food-reinforced instrumental training. European Journal of Neuroscience 2012, 35:1354-1367.
49. Shenolikar S., Nairn A.C. Protein phosphatases: recent progress. Advances in Second Messenger and Phosphoprotein Research 1991, 23:1-121.
50. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behavioural Brain Research 1998, 94:127-152.
51. Solanto M.V. Clinical psychopharmacology of AD/HD: implications for animal models. Neuroscience and Biobehavioral Reviews 2000, 24:27-30.
52. Stipanovich A., Valjent E., Matamales M., Nishi A., Ahn J.H., Maroteaux M., et al. A phosphatase cascade by which rewarding stimuli control nucleosomal response. Nature 2008, 453:879-884.
53. Svenningsson P., Nishi A., Fisone G., Girault J.A., Nairn A.C., Greengard P. DARPP-32: an integrator of neurotransmission. Annual Review of Pharmacology and Toxicology 2004, 44:269-296.
54. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Archives of General Psychiatry 1995, 52:456-463.
55. Walaas S.I., Aswad D.W., Greengard P. A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 1983, 301:69-71.
56. Walaas S.I., Nairn A.C., Greengard P. Regional distribution of calcium- and cyclic adenosine 3':5'-monophosphate-regulated protein phosphorylation systems in mammalian brain. II. Soluble systems. Journal of Neuroscience 1983, 3:302-311.
57. Wetzel C.D., Squire L.R., Janowsky D.S. Methylphenidate impairs learning and memory in normal adults. Behavioral and Neural Biology 1981, 31:413-424.
58. Yger M., Girault J.A. DARPP-32, Jack of all trades. . master of which?. Frontiers in Behavioral Neuroscience 2011, 5:56.
59. Zachariou V., Benoit-Marand M., Allen P.B., Ingrassia P., Fienberg A.A., Gonon F., et al. Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1. Biological Psychiatry 2002, 51:612-620.
60. Zhang Y., Svenningsson P., Picetti R., Schlussman S.D., Nairn A.C., Ho A., et al. Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. Journal of Neuroscience 2006, 26:2645-2651.